Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870869 · ClinicalTrials.gov registry record · NA
NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study
A NA study, sponsored by Allergan.
- Terminated
- Registry status
- NA
- Development phase
- 1,951
- Enrollment target
NCT01870869: Clinical Trial NA study, sponsored by Allergan.
NCT01870869 is a NA study that was terminated before completion, run by Allergan. The registered enrollment target is 1,951 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01870869, a NA study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,951 participants
- Enrollment target
Study Summary
This study is a prospective, multicenter, nonrandomized study to provide access to and evaluate the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled X-Style and L-Style Breast Implants for breast augmentation, reconstruction, or revision.
Primary Outcome
The investigator rated their satisfaction with the participant's breast implant for each breast on a 5-point scale (1=Definitely dissatisfied, 2=Somewhat dissatisfied, 3=Neither satisfied or dissatisfied, 4=Somewhat satisfied, 5=Definitely satisfied). If there was a different response for the left and right breasts the worst response was used. The percentage of participants where the investigator responded: "Definitely satisfied" or "Somewhat satisfied" is reported.
Interventions
- DEVICE Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,951 participants |
| Start Date | 2013-05-29 |
| Est. Completion | 2015-11-30 |
| Phase | NA |
Why NCT01870869 stopped before completion
NCT01870869 is an interventional study that assigns participants to a tested intervention. Its 1,951 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% higher).
The record links to 0 conditions, and to 1 intervention - of which Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection is the first listed.
NCT01870869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01870869 about?
NCT01870869 is a clinical study titled "NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study". This study is a prospective, multicenter, nonrandomized study to provide access to and evaluate the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled X-Style and L-Style Breast Implants for breast augmentation, reconstruction, or revision.
What is the current status of trial NCT01870869?
This trial is currently terminated. It is a NA study. The enrollment target is 1,951 participants. The study started on 2013-05-29. Estimated completion is 2015-11-30.
What interventions are being tested in trial NCT01870869?
The interventions under investigation include: Anatomically shaped, silicone-filled breast implants with low height/projection or extra-full projection (DEVICE).
Who is sponsoring clinical trial NCT01870869?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01870869's enrollment target sits among peer trials
1,951 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI